Steve Christo – Corbis | Corbis News | Getty Images Novo Nordisk‘s blockbuster diabetes drug …
Alzheimers
-
-
Mutual FundsNews
Cassava’s Stock Drops After It Agrees to Pay $40M to Settle SEC Alzheimer’s Claims
by adminKey Takeaways Cassava Sciences and two former executives agreed to pay more than $40 million …
-
BusinessHealth CareNews
Eli Lilly to boost output of weight loss, diabetes, Alzheimer’s drugs
by adminA sign with the company logo sits outside of the headquarters of Eli Lilly in …
-
BusinessHealth CareNews
Leqembi could give Alzheimer’s patients more time, but road to treatment is long
by adminHannah Yoon | The Washington Post | Getty Images Leqembi, an Alzheimer’s drug from Biogen …
-
BusinessHealth CareNews
Eisai Biogen Alzheimer’s drug Leqembi shows benefits over three years
by adminThe newly FDA approved Alzheimer’s treatment Leqembi is prepared at Abington Neurological Associates in Abington, …
-
A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter …
-
BusinessHealth CareNews
Biogen Eisai Alzheimer’s drug Leqembi rejected by European regulator
by adminEuropean drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating …
-
-
Key Takeaways Eli Lilly received FDA approval for a drug to help treat Alzheimer’s on …
-
A sign with the company logo sits outside of the headquarters campus of Eli Lilly …
-
BusinessHealth CareNews
FDA approval of Eli Lilly’s Alzheimer’s drug cements our decision not to take profits
by adminEvery weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable …
-
-
Mutual FundsNews
Eli Lilly Stock Gains After FDA Advisors Recommend Alzheimer’s Drug Donanemab
by adminKey Takeaways Eli Lilly shares rose in extended-hours trading on Monday after a panel of …
-
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & …
- 1
- 2